The British Neuroscience Association (BNA) is a key player in the neuroscience sector, supporting professionals and promoting interdisciplinary collaboration. Chief Executive Dr Laura Ajram highlights the importance of bridging advanced neurological research with public understanding and the latest developments in the field.
Digital biomarker can identify which cases of mild cognitive impairment will develop into Alzheimer’s so that early interventions can be put in place to prevent the onset of the disease.
Tara M. DeSilva from the Department of Neurosciences, Cleveland Clinic, walks us through regenerative therapies for multiple sclerosis, including comment on clues from studying normal brain development.
One of JPND’s key objectives is to fortify its work in brain health partnerships in Europe to better combat the challenges of neurodegenerative disease (ND).
Open Access Government discerns the priorities of the Institute of Neurosciences, Mental Health and Addiction, which examines Health research in Canada.
Looking at speech patterns throughout history, the processing of language is based on how frequently we hear sounds - which causes gradual language change.
Scientists find that persistent cognitive symptoms of the virus, known as COVID brain fog, can be equivalent to 20 years of ageing or losing 10 IQ points.
Psychedelic drugs have recently been used to treat mental health disorders – now scientists find they can also provide better understanding into the attribution of consciousness.
Advancing neuroscience research improves quality of life for all people with neurological disorders, and ultimately can prevent or cure these diseases. Open Access Government highlight some research priorities in neuroscience.
Sean Lawler, Associate Professor at Brown University, explains solving the riddle when it comes to the cytomegalovirus virus and the lethal brain tumour, glioblastoma.
The healthier pre-industrial lifestyles which Indigenous communities live by present solutions in preventing Alzheimer’s and dementia – as seen in their lower rates of the disease.
